Eli Lilly said on Monday it has sued two medical spas for selling unapproved products claiming to contain tirzepatide, the ...

Hims & Hers reported impressive third-quarter results in November, with earnings of 32 cents per share, far exceeding analyst ...

Eli Lilly moves to defend FDA's tirzepatide shortage resolution amid criticism over supply issues and compounding pharmacy ...

On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and ...

Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...

Scots nurse Susan McGowan died after just two low doses of a weight-loss jab. Susan, 58, took medical advice before using ...

"We're suckers for quick fixes," Emily Feivor, a registered dietician, tells PEOPLE about the claim that honey, lemon, water, ...

In another instance, a patient who came to India for treatment from the Middle East, requested a prescription for a Tirzepatide injection, even before the drug had arrived on Indian shores.” ...

As expected by many, Eli Lilly And Co (NYSE:LLY) filed a motion to intervene as a defendant in a case between the Outsourcing Facilities Association and FarmaKeio Custom Compounding against the FDA.

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

What happened: In early October, the FDA determined that Eli Lilly’s tirzepatide injection shortage had been resolved. The U.S. health regulator reminded compounders of the legal restrictions on ...